<List><item><source>MED</source><extId>28275958</extId><pmcid>PMC5380505</pmcid><annotations><annotation><prefix>; EXAMINE ClinicalTrials.gov number, </prefix><exact>NCT00968708</exact><postfix>). </postfix><tags><tag><name>NCT00968708</name><uri>http://identifiers.org/clinicaltrials/NCT00968708</uri></tag></tags><id>http://europepmc.org/abstract/MED/28275958#europepmc-5f8c5cc42adf8764f9d6e756abf71e97</id><type>Accession Numbers</type><section>Abstract (http://purl.org/dc/terms/abstract)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>ls.gov (Identifier: </prefix><exact>NCT01590771</exact><postfix>) [33], taking the t</postfix><tags><tag><name>NCT01590771</name><uri>http://identifiers.org/clinicaltrials/NCT01590771</uri></tag></tags><id>http://europepmc.org/articles/PMC5380505#europepmc-85a81e39de4c16f42d30308ff96cbc24</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>(ClinicalTrial.gov: </prefix><exact>NCT01099137</exact><postfix>) where the patients</postfix><tags><tag><name>NCT01099137</name><uri>http://identifiers.org/clinicaltrials/NCT01099137</uri></tag></tags><id>http://europepmc.org/articles/PMC5380505#europepmc-aea6b76d97dfa7507f706cbe56703376</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>Owens et al. [5], ClinicalTrials.gov </prefix><exact>NCT00602472</exact><postfix>). </postfix><tags><tag><name>NCT00602472</name><uri>http://identifiers.org/clinicaltrials/NCT00602472</uri></tag></tags><id>http://europepmc.org/articles/PMC5380505#europepmc-814736f15b5d089736afccad5ab4a95f</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>rials (Hermansen et al. [4] and </prefix><exact>NCT01590771</exact><postfix> [33]). </postfix><tags><tag><name>NCT01590771</name><uri>http://identifiers.org/clinicaltrials/NCT01590771</uri></tag></tags><id>http://europepmc.org/articles/PMC5380505#europepmc-1557c0af40148416b07d73d4f63a17ef</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>vich et al. [6] and </prefix><exact>NCT01590771</exact><postfix> [33] which had rela</postfix><tags><tag><name>NCT01590771</name><uri>http://identifiers.org/clinicaltrials/NCT01590771</uri></tag></tags><id>http://europepmc.org/articles/PMC5380505#europepmc-6b3a065d667636335c12ff64934acfd0</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>